FAQ

General Questions

Q: When and where is the conference taking place?
A: TRI-CON 2025 will be held on March 11-13th, 2025 in San Diego, California. Both in-person and virtual attendance options are available for flexibility. Visit travel page to learn more.

Q: What is the Precision Medicine Tri-Con?
The Precision Medicine Tri-Con is an annual conference focused on strategies in precision medicine and diagnostics. Key program areas include AI in precision medicine, implementing precision medicine strategies, liquid biopsy innovations, spatial biology and more.

Q: Who should attend TRI-CON 2025?
Whether you’re a researcher, healthcare professional, investor, or executive, TRI-CON is designed for anyone interested in advancing precision medicine, diagnostics, and drug development. Explore the agenda to find sessions tailored to your expertise.


Program-Specific Questions

Q: What topics will be covered during the conference?
The conference agenda spans several key tracks, including:

  • Precision Medicine
  • Liquid Biopsy
  • Multi-cancer early detection
  • Emerging Technologies
  • AI Utility in precision medicine
  • Spatial Biology
  • Companion Diagnositcs
  • Clinical Biomarkers
  • Point-of-Care Diagnostics

Visit the Program Page for a full schedule of featured speakers.

Q: What sessions focus on AI in precision medicine?
The program features multiple tracks dedicated to AI applications, including advanced machine learning techniques, predictive analytics, and AI utility in precision oncology.

Q: What is covered under the Liquid Biopsy track?
A: The Liquid Biopsy track covers breakthroughs in non-invasive diagnostic techniques, including biomarker discovery, early cancer detection, and liquid biopsy applications in monitoring disease progression.

For full program coverage at TRI-CON visit https://www.triconference.com/programs



Register Now
March 11-12, 2025

Artificial Intelligence in Precision Medicine

Implementing Precision Medicine

At-Home & Point-of-Care Diagnostics

Liquid Biopsy

Spatial Biology and Single-Cell Multiomics

March 12-13, 2025

Diagnostics Market Access

Precision Medicine Beyond Oncology

Infectious Disease Diagnostics

Multi-Cancer Early Detection

Clinical Biomarkers & Companion Diagnostics